Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Zefylti |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (12 Feb 2025), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neutropenia | EU | 12 Feb 2025 | |
Neutropenia | IS | 12 Feb 2025 | |
Neutropenia | LI | 12 Feb 2025 | |
Neutropenia | NO | 12 Feb 2025 |